Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose
Uveitis for the non-ophthalmologist
3 February 2021New pregnancy healthy eating app backed by clinical research
3 February 2021Oxford coronavirus vaccine shows sustained protection of 76% during the 3-month interval until the second dose
Researchers at the University of Oxford have today published in Preprints with The Lancet an analysis of further data from the ongoing trials of the vaccine. In this, they reveal that the vaccine efficacy is higher at longer prime-boost intervals, and that a single dose of the vaccine is 76% effective from 22- to up to 90-days post vaccination.
